Drug Discovery

56 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

Key players

OpenAI Anthropic Co-Scientist Co-Scientist Google DeepMind Isomorphic Labs

Monday, 20 July 2026

Apply for Anthropic’s AI for Science rare disease research grants

Anthropic 29

Anthropic launched a grant program offering up to $50,000 in Claude API credits over six months to researchers and biotech companies working on rare genetic disease research. The program has two tracks: one for basic science researchers partnering with organizations like the Monarch Initiative to discover disease mechanisms, and another for early-stage biotechs accelerating drug development. Applications are open through August 2, 2026, with the goal of building a community that uses AI to identify patterns across rare diseases and compress clinical development timelines.

Read the full story

Anthropic Healthcare AI Drug Discovery

Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin

NVIDIA 2 months ago 51 ● 8 sources

Bristol Myers Squibb deployed its second NVIDIA DGX SuperPOD with eight Vera Rubin NVL72 systems, doubling down on AI infrastructure for drug discovery. The new system delivers 10x the performance per megawatt compared to its predecessor and will be accessible to all BMS scientists globally through a unified AI platform including NVIDIA BioNeMo Agent Toolkit. This removes computational bottlenecks and enables faster drug discovery cycles by democratizing access to supercomputing resources across the organization's research pipeline.

Read the full story

AI Infrastructure Drug Discovery

Every AI story that matters,
in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.